• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用固体分散体提高口服给药的药物溶解度。

Improving drug solubility for oral delivery using solid dispersions.

作者信息

Leuner C, Dressman J

机构信息

Johann Wolfgang Goethe University, Frankfurt am Main, Germany.

出版信息

Eur J Pharm Biopharm. 2000 Jul;50(1):47-60. doi: 10.1016/s0939-6411(00)00076-x.

DOI:10.1016/s0939-6411(00)00076-x
PMID:10840192
Abstract

The solubility behaviour of drugs remains one of the most challenging aspects in formulation development. With the advent of combinatorial chemistry and high throughput screening, the number of poorly water soluble compounds has dramatically increased. Although solid solutions have tremendous potential for improving drug solubility, 40 years of research have resulted in only a few marketed products using this approach. With the introduction of new manufacturing technologies such as hot melt extrusion, it should be possible to overcome problems in scale-up and for this reason solid solutions are enjoying a renaissance. This article begins with an overview of the historical background and definitions of the various systems including eutectic mixtures, solid dispersions and solid solutions. The remainder of the article is devoted to the production, the different carriers and the methods used for the characterization of solid dispersions.

摘要

药物的溶解性是制剂研发中最具挑战性的方面之一。随着组合化学和高通量筛选的出现,难溶性化合物的数量急剧增加。尽管固体溶液在改善药物溶解性方面具有巨大潜力,但40年的研究仅产生了少数采用这种方法的上市产品。随着热熔挤出等新制造技术的引入,应该有可能克服放大生产中的问题,因此固体溶液正在复兴。本文首先概述了包括低共熔混合物、固体分散体和固体溶液在内的各种体系的历史背景和定义。本文的其余部分致力于固体分散体的生产、不同载体以及用于表征固体分散体的方法。

相似文献

1
Improving drug solubility for oral delivery using solid dispersions.使用固体分散体提高口服给药的药物溶解度。
Eur J Pharm Biopharm. 2000 Jul;50(1):47-60. doi: 10.1016/s0939-6411(00)00076-x.
2
Review of solubilization techniques for a poorly water-soluble drug: carbamazepine.难溶性药物卡马西平的增溶技术综述
PDA J Pharm Sci Technol. 2010 May-Jun;64(3):264-77.
3
Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.包含难溶性药物的固体分散体的当前趋势和未来展望。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):799-813. doi: 10.1016/j.ejpb.2013.09.007. Epub 2013 Sep 18.
4
The role of the carrier in the formulation of pharmaceutical solid dispersions. Part I: crystalline and semi-crystalline carriers.载体在药物固体分散体处方中的作用。第一部分:结晶和半结晶载体。
Expert Opin Drug Deliv. 2016 Nov;13(11):1583-1594. doi: 10.1080/17425247.2016.1198768. Epub 2016 Jun 20.
5
Eutectic mixtures as an approach to enhance solubility, dissolution rate and oral bioavailability of poorly water-soluble drugs.共晶混合物作为一种提高低水溶性药物溶解度、溶出速率和口服生物利用度的方法。
Int J Pharm. 2020 Oct 15;588:119741. doi: 10.1016/j.ijpharm.2020.119741. Epub 2020 Aug 9.
6
Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century.热熔挤出技术对21世纪药物递送进展的贡献。
Expert Opin Drug Deliv. 2016;13(3):451-64. doi: 10.1517/17425247.2016.1126246. Epub 2015 Dec 19.
7
Solid dispersions in pharmaceutical technology. Part I. Classification and methods to obtain solid dispersions.药物技术中的固体分散体。第一部分。固体分散体的分类及制备方法。
Polim Med. 2012;42(1):17-27.
8
Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.固体分散体改善亲脂性药物的溶出行为:从生产工艺角度出发考虑制剂问题。
Expert Opin Drug Deliv. 2011 Sep;8(9):1121-40. doi: 10.1517/17425247.2011.598147. Epub 2011 Jul 2.
9
Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.利用 Flory-Huggins 相图作为制备无定形固体分散体的预配方工具:热熔挤出法和喷雾干燥法的比较。
J Pharm Pharmacol. 2014 Feb;66(2):256-74. doi: 10.1111/jphp.12141. Epub 2013 Nov 5.
10
Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.在制备难溶性活性药物成分的固体分散体中使用表面活性剂作为增塑剂:所选固体分散体的稳定性测试
Pharm Res. 2006 Aug;23(8):1928-36. doi: 10.1007/s11095-006-9034-1.

引用本文的文献

1
Data-driven organic solubility prediction at the limit of aleatoric uncertainty.在偶然不确定性极限下的数据驱动有机溶解度预测。
Nat Commun. 2025 Aug 19;16(1):7497. doi: 10.1038/s41467-025-62717-7.
2
Design and fabrication of a mesoporous silica scaffold for oral delivery of peptides.用于肽口服递送的介孔二氧化硅支架的设计与制备
Sci Rep. 2025 Aug 12;15(1):29520. doi: 10.1038/s41598-025-12728-7.
3
Ternary Solid Dispersions as an Alternative Approach to Enhance Pharmacological Activity.三元固体分散体作为增强药理活性的替代方法。
Drug Des Devel Ther. 2025 Jul 3;19:5663-5684. doi: 10.2147/DDDT.S533359. eCollection 2025.
4
Identification of PEDV inhibitors targeting 3CL protease.靶向3CL蛋白酶的猪流行性腹泻病毒抑制剂的鉴定
Virol Sin. 2025 Jun 27. doi: 10.1016/j.virs.2025.06.002.
5
Phospholipid/HP-β-CD Hybrid Nanosystems Amplify Neohesperidin Bioavailability via Dual Enhancement of Solubility and Stability.磷脂/羟丙基-β-环糊精杂化纳米系统通过双重增强溶解度和稳定性提高新橙皮苷的生物利用度。
Nanomaterials (Basel). 2025 Jun 3;15(11):862. doi: 10.3390/nano15110862.
6
Freeze-Drying as a Tool for Preparing Porous Materials: From Proof of Concept to Recent Pharmaceutical Applications.冷冻干燥作为制备多孔材料的工具:从概念验证到近期的药物应用
AAPS PharmSciTech. 2025 Jun 3;26(5):159. doi: 10.1208/s12249-025-03117-4.
7
Influence of Ionization and the Addition of Cyclodextrins and Hydrophilic Excipients on the Solubility of Benzthiazide, Isoxicam, and Piroxicam.电离以及环糊精与亲水性辅料的添加对苄噻嗪、异恶酰胺和吡罗昔康溶解度的影响。
Pharmaceutics. 2025 Apr 25;17(5):571. doi: 10.3390/pharmaceutics17050571.
8
Mechanistic Advances in the Therapeutic Application of Bixin for Lung Inflammation In Vitro and In Vivo.胭脂树素在体内外治疗肺部炎症中的作用机制进展
Pharmaceuticals (Basel). 2025 Apr 5;18(4):530. doi: 10.3390/ph18040530.
9
Combining High-Throughput Screening and Machine Learning to Predict the Formation of Both Binary and Ternary Amorphous Solid Dispersion Formulations for Early Drug Discovery and Development.结合高通量筛选和机器学习预测二元和三元无定形固体分散体配方的形成,用于早期药物发现和开发。
Pharm Res. 2025 Apr;42(4):697-709. doi: 10.1007/s11095-025-03853-z. Epub 2025 Apr 3.
10
Mechanistic Investigation into the Phase Separation Behavior of Soluplus in the Presence of Biorelevant Media.在生物相关介质存在下对固体分散体载体(Soluplus)相分离行为的机理研究。
Mol Pharm. 2025 Apr 7;22(4):1958-1972. doi: 10.1021/acs.molpharmaceut.4c01140. Epub 2025 Mar 11.